more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$618.46 USD

-5.75 (-0.92%)

Updated Sep 11, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

Top 29% (72 out of 250)

Industry: Medical - Instruments

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

What's in Store for Patterson Companies' (PDCO) Q1 Earnings?

by Zacks Equity Research Published on September 01,2020

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect sluggishness at Dental segment.

Here's Why You Should Invest in LHC Group (LHCG) Stock Now

by Zacks Equity Research Published on September 01,2020

LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.

medical

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research Published on August 31,2020

Cooper Companies' (COO) fiscal third-quarter performance is likely to reflect weak performance by CVI and CSI.

Medtronic's (MDT) Cryoablation Suited for Patients With PAF

by Zacks Equity Research Published on August 31,2020

Medtronic's (MDT) cryoablation therapy's superiority for the treatment of PAF over currently available AAD treatment gets reflected in trial results.

medical

Medtronic (MDT) Sees Trend Rebound Amid Coronavirus Crisis

by Zacks Equity Research Published on August 31,2020

Medtronic's (MDT) procedure volumes start to recover in multiple markets globally.

medical

5 Solid Dividend Growth Stocks to Buy Now

by Sweta Killa Published on August 31,2020

Dividend investing has been gaining immense popularity amid low rates and super-easy monetary policy.

Hologic Updates Breast Biopsy System to Enhance Workflow

by Zacks Equity Research Published on August 31,2020

Hologic (HOLX) introduces features to update Brevera Breast Biopsy System in order to transform patient experience and enhance workflow.

medical

Veeva Systems (VEEV) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research Published on August 28,2020

Veeva Systems' (VEEV) core Subscription business segment performs impressively in Q2.

Bruker Rides on MALDI Launches Amid Coronavirus-Led Crisis

by Zacks Equity Research Published on August 27,2020

For higher specific detection of the SARS-CoV-2 virus, Bruker (BRKR) launches luoroType SARS-CoV-2 plus next-generation 6-plex PCR assay.

Phibro (PAHC) Q4 Earnings Fall Short of Estimates, Margins Up

by Zacks Equity Research Published on August 27,2020

Phibro's (PAHC) core Animal Health segment was aided by the Osprey Biotechnics acquisition despite a dismal overall performance in Q4 due to pandemic-led business disruptions.

AMN Healthcare's Advanced Mobile App to Aid Travel Clinicians

by Zacks Equity Research Published on August 27,2020

AMN Healthcare's (AMN) new version of AMN Passport will benefit travel clinicians.

medical

Hologic's Acessa Health Buyout to Broaden GYN Surgical Line

by Zacks Equity Research Published on August 26,2020

Hologic's (HOLX) newly-acquired product line is set to complement its market-leading MyoSure products for hysteroscopic removal of fibroids.

medical

Align Technology (ALGN) Strong on Robust Customer Adoption

by Zacks Equity Research Published on August 26,2020

Align Technology (ALGN) treats the one millionth patient from the APAC region, highlighting the Invisalign system's continued adoption.

medical

Allscripts Enhances Healthcare Innovation With Patent Program

by Zacks Equity Research Published on August 26,2020

Allscripts (MDRX) continues to advance healthcare innovation by earning five new application patents.

medical

Here's Why You Should Hold on to DENTSPLY (XRAY) Stock Now

by Zacks Equity Research Published on August 26,2020

DENTSPLY (XRAY) continues to gain traction from its solid focus on R&D leading to product innovation, which continues to be a key catalyst.

medical